Comunicati.net - Comunicati pubblicati - Editoria Comunicati.net - Comunicati pubblicati - Editoria Tue, 28 Jan 2020 09:08:16 +0100 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://comunicati.net/comunicati/aziende/editoria/1 8.6% CAGR Is Marked In Tissue Glue And Bio Adhesive Sealants Market With The Value of US$ 2,281.2 Mn By 2024 Mon, 27 Jan 2020 15:34:47 +0100 http://comunicati.net/comunicati/aziende/editoria/617196.html http://comunicati.net/comunicati/aziende/editoria/617196.html persistencemarketresearch persistencemarketresearch  

The growing demand for advances and highly effective adhesives continues to influence manufacturers to develop alternative glues and cementing materials. In 2015, the global sales of tissue glue and bio-adhesive sealants were recorded to exceed  US $ 1.1 billion , indicating a promising scope of growth in terms of revenues. According to Persistence Market Research's recent report titled " Tissue Glue and Bio-adhesive Sealants Market:  Global Industry Analysis & Forecast, 2016-2024 global revenues will reach  US $ 2,281.2 million  by the end of 2024.

By end-user, hospitals will dominate global revenues, as compared to specialty clinics and ambulatory surgical centers (ASCs). In terms of application, the report has forecasted cardiovascular surgeries to account for the highest revenue share. Surpass one billion dollar mark by 2024.

Ethicon Inc. & Baxter International: Dominant Market Players

Local and regional pharmaceutical manufacturers have been actively participating in the global  tissue glue and bio-adhesive sealants market , collectively accounting for 14% -15% market share. Key findings from the research have indicated that Ethicon, Inc., a Johnson & Johnson subsidiary that manufactures wound sealing devices and surgical sutures is the largest player in the global market. With over 40% company share, Ethicon (US) has independently expanded its outright dominance in the global tissue glue and bio-adhesive sealants market.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/12898

Second in line is US-based medical products manufacturer, Baxter International Inc., which contributes to an estimated 22.6% share of global market revenues.

Company Profiles

  • Cryolife
  • Baxter International Inc.
  • Luna Innovations Incorporated
  • B. Braun Melsungen AG
  • Johnson and Johnson
  • DENTSPLY SIRONA Inc.
  • Cohera Medical, Inc.
  • Chemence Medical, Inc.
  • Tissuemed Ltd.
  • C.R. Bard Inc.
  • Integra LifeSciences Corporation
  • Others

For Critical Insights On The Tissue Glue And Bio Adhesive Sealants Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/12898

Global Sales Analysis: High Demand for Fibrin Sealants

Product-wise breakdown of global tissue glue and bio-adhesive sealants sales recorded throughout the forecast period have indicated higher demand for fibrin sealants. Global consumption of fibrin sealants in 2016 is estimated to account for nearly US$ 500 million in revenues.

Compared to fibrin sealants, the collective revenues generated from sales of protein-based sealants and thrombin-based sealants in the global market are projected to secure over 40% value share by the end of 2024. Meanwhile, sales of collage-based sealants and gelatin-based sealants are predicted to incur a slight dip over the forecast period.

Regional Analysis of Tissue Glue and Bio-adhesive Sealants Sales

The market size of the global tissue glue and bio-adhesive sealants market spans several key regions that endure distinctive growth throughout the forecast period. North America’s tissue glue and bio-adhesive sealants market is estimated to dominate with more than 50% share of global market value.

Technological influence and enhanced healthcare infrastructure are attributed to promote the growth of the tissue glue and bio-adhesive sealants market in North America. Meanwhile, qualitative production and an extensive consumer base has rendered Asia Pacific (APAC) as the second most lucrative region in the global tissue glue and bio-adhesive sealants market.

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/12898

Through 2024, the APAC tissue glue and bio-adhesive sealants market is likely to expand at the highest regional  CAGR of 8.6% . Other key insights on regional analysis of the global tissue glue and bio-adhesive sealants market, compiled in the report, includes:

  • Europe's tissue glue and bio-adhesive sealants sales to incur impedance due to supply chain and distribution issues, and an undulating fluctuation within the region's currency rates
  • Tissue glue and bio-adhesive sealants market in the Middle East & Africa (MEA) region will expand at a comparatively lesser CAGR over the forecast period
  • Between 2016 and 2017, Latin America is expected to endure an estimated market value increment of over US $ 4 million
]]>
15.2% CAGR Is Marked In Proton Therapy Systems Market With The Value of US$ 3,000 Mn By 2024 Mon, 27 Jan 2020 15:34:25 +0100 http://comunicati.net/comunicati/aziende/editoria/617195.html http://comunicati.net/comunicati/aziende/editoria/617195.html persistencemarketresearch persistencemarketresearch

Growing prevalence of cancer has prompted medical organizations towards development and adoption of advanced treatment procedures, such as proton radiotherapy. The effectiveness of proton therapy continues to gain trust of cancer patients across the globe.

The procedure is known for successfully destructing tumor cells by damaging their DNA through a targeted deposition of high-energy radiation dosage onto the tumor. Furthermore, doctors treating cancer patients are also benefiting from the feasibility of proton therapy as it can be used in conjunction with other treatments.

Factors as such continue to promote the adoption of proton therapy for curing cancerous abnormalities. Persistence Market Research projects that by the end of 2024, the global market for proton therapy will bring in more than US$ 2,926.7 Mn in revenues.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/12358

In the report, titled “Proton Therapy Market: Global Industry Analysis and Forecast, 2016-2024,” the global market for proton therapy is presently valued at closed to US$ 945 Mn and is projected to soar at a healthy CAGR of 15.2%. The report estimates that governments from all corners of the globe will continue to shore up their healthcare expenditure on cancer care facilities, which will incidentally boost the revenues in global proton therapy market. Additional benefits of availing proton therapy, compared to chemotherapy or radiation therapy, will also instrument a steadfast revenue growth for the market.

Based on a regional analysis compiled in the report, North America is projected to account for a little less than one-third share of global proton therapy revenues throughout the forecast period. However, Europe’s proton therapy market will dominate with close to 38% share and showcase revenue growth at 15.7% CAGR. The report has also profiled leading players in the global proton therapy market,

For Critical Insights On The Proton Therapy Systems Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/12358

Company Profiles

  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • ProNova Solutions, LLC
  • ProTom International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems
  • Others

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/12358 

Key highlights of the research report on global proton therapy market follow:

  • The market is likely to benefit from companies manufacturing compact set up used in proton beam therapy, which help in saving production costs without impairing product efficacy
  • Based on such set ups, multiple-room proton therapy will gain traction by accounting for more than three-fourth of global revenues towards the end of forecast period
  • Among multiple cancer indications, the adoption of proton therapy will be relatively higher for treatment of lung cancer, gastro-intestinal cancer, pediatric cancer, head & neck cancer
  • Flexible payment options are also boosting the supply of proton therapy devices, while affordability of such devices continues to be a major challenge
  • The report also predicts that the demand for proton therapy will be impacted by the therapy's side-effects which includes fatigue, skin irritation, swelling and skin blistering
  • Nonetheless, the market will witness opportunistic growth in terms of rising preference to non-invasive treatment of cancerous tumors
]]>
7.9% CAGR Is Marked In Microrna Market With The Value of US$ 187.8 Mn By 2025 Mon, 27 Jan 2020 15:34:03 +0100 http://comunicati.net/comunicati/aziende/editoria/617194.html http://comunicati.net/comunicati/aziende/editoria/617194.html persistencemarketresearch persistencemarketresearch

Global  microRNA market  is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by increasing demand of microRNA re-agents and kits for various applications that could eventually translate into developing innovative therapeutic solutions for various difficult-to-treat illnesses

. According to the new report published by Persistence Market Research titled, " MicroRNA Market : Global Industry Analysis (2012-2016) and Forecast (2017-2025)," which tracks the performance of global microRNA market for the period of eight years, ie 2017 -2025, the global market is projected to register a  CAGR of 7.9%  in terms of value during the forecast period. The market is anticipated to be valued at  US $ 666.7 Mn by 2025 .

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/3464

Global MicroRNA Market: Restraints

  • Poor reproducibility of research and specificity of products
  • Complication in vendor selection due to large product portfolios
  • Requirement of skilled personnel and limited availability of data analysis tools
  • In-house development of assays for microrna detection
  • RNA is more challenging to handle
  • High cost associated with microrna reagents and other similar products
  • Limited life science research infrastructure in emerging markets

Global MicroRNA Market: Forecast by Assay Type

On the basis of assay type, the global microRNA market is segmented into PCR-based Assay, miRNA Arrays, Next Generation Sequencing (NGS), and Immunoassay. Immunoassay segment is further segmented into Fluorescent Assays, Colorimetric Assays, and Chemiluminescent Assays.

On the basis of assay type, PCR based arrays segment accounted for 34.9% market share in 2016 in terms of revenue, which is expected to increase to 36.9% by 2025 end. Next generation sequencing is expected to be the second largest segment in terms of revenue growth in microRNA market and is expected to register a CAGR of 8.1% over the forecast period.

For Critical Insights On The Microrna Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/3464

Global MicroRNA Market: Forecast by Application

On the basis of application, the global microRNA market is segmented into Clinical Diagnostics and Research. Research is the largest segment in global microRNA market, which is estimated to represent US$ 275.7 Mn, or 76.1% share of the total market in 2017 and US$ 525.6 Mn, or 78.8% by 2025 end, expanding at CAGR of 8.4% over the forecast period.

Research segment dominated the global microRNA market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Research segment is expected to be the most lucrative among all end users, with attractiveness index of 1.6.

Global MicroRNA Market: Forecast by End User

On the basis of end-user, the global microRNA market is segmented into Academic and Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, and Diagnostic Centers. Academic & research institutes end user is the largest segment in global microRNA market, which is estimated to represent US$ 138.9 Mn of the total market in 2017 and is anticipate to be valued at US$ 255.9 Mn by 2025 end, expanding at CAGR of 7.9% over the forecast period. Academic & research institutes dominated the global microRNA market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period.

Global MicroRNA Market: Forecast by Region

Five regions have covered in this report such as North America, Latin America, Europe, APAC and MEA. North America is the largest region in microRNA market, which is estimated to represent US$ 140.3 Mn, or 38.7% share of the total market in 2017 and is projected to reach to US$ 245.9 Mn, or 36.9%, expanding at CAGR of 7.3% over the forecast period of 2017–2025. Europe is expected to be the second most lucrative market, with attractiveness index of 1.3 during the forecast period.

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/3464

Global MicroRNA Market: Key Players

Company Profiles

  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies
  • Bio-Rad Laboratories Inc.
  • Sigma Aldrich Corp.
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.
  • HTG Molecular Diagnostics, Inc.
  • Bioline GmbH (A Meridian Life Science Company)
  • Rosetta Genomics Ltd.
  • Dharmacon, to Horizon Discovery Group Co.
  • BioVendor - Laboratorní medicína as
  • Miltenyi Biotec
  • Kaneka Corporation (Eurogentec)
  • Abcam Plc
  • GeneCopoeia, Inc.
  • Promega Corporation
  • New England Biolabs, Inc.
  • NanoString Technologies, Inc.
  • System Biosciences LLC
  • Others.
]]>
5.3% CAGR Is Marked In Invisible Orthodontics Market With The Value of US$ 4,860.4 Mn By 2028 Mon, 27 Jan 2020 15:33:41 +0100 http://comunicati.net/comunicati/aziende/editoria/617193.html http://comunicati.net/comunicati/aziende/editoria/617193.html persistencemarketresearch persistencemarketresearch

According to the latest research, the global invisible orthodontics market is projected to account for a market value of  US $ 4,860.4 Mn by the end of 2028 . The PMR report has projected healthy growth potential for the  invisible orthodontics market  throughout the forecast period.

Malocclusion is a malrelationship of the dental arches or irregularity of the teeth and is considered as a prominent public health problem due to its growing prevalence alongside prevention and treatment possibilities. In terms of prevalence, malocclusion is worse for rank third among oral pathologies, after tooth decay and periodontal disease.

Malocclusions can lead to various implications such as disturbances of oral function, including swallowing, mastication and speech, greater susceptibility to periodontal disease and trauma, and psychosocial problems related to impaired dentofacial aesthetics.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/13498

Significantly increase in the adoption of orthodontics treatment, owing to the increased prevalence of malocclusions and dental diseases further increases the use of invisible orthodontics such as braces and brackets systems. Various manufacturers in the invisible orthodontics market are focusing on developing invisible braces, owing to the increasing adoption of invisible orthodontics products over traditional metal braces.

The demand for invisible orthodontics in treating both adolescents and adults and development of better treatment options are on the rise. Improvement in invisible orthodontics technology with the development of new aesthetic material, computerized imaging systems, and distraction osteogenesis will further increase the demand for invisible orthodontics.

The development and adoption of novel technologies in invisible orthodontics helps in enhancing the level of treatment and delivering impressive results for the treatment of orthodontics procedures.

The global invisible orthodontics market can be segmented on the basis of product type, application, age group, end user and region.

For Critical Insights On The Invisible Orthodontics Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/13498

In terms of revenue, the clear aligners segment of the invisible orthodontics market is expected to remain prominent during the forecast period.

  • By application, the crowding segment of the invisible orthodontics market is expected to hold a significant share during the forecast period.
  • By age group, the adult segment of the invisible orthodontics market is expected to be the most lucrative during the forecast period.
  • By end user, the hospitals segment is expected to be the most lucrative segment in the invisible orthodontics market during the forecast period.
  • By region, North America is pegged to be a prominent region in the global invisible orthodontics market.

The development and adoption of novel technologies helps in enhancing the level of treatment and delivering impressive results for orthodontic procedures. With the introduction of clear, self-ligating and invisible braces in orthodontics, which are far more efficient, effective and discreet, teeth can be straightened without elastic bands with aligners and clear ceramic braces such as Invisalign, which are hardly noticeable. This further increases the acceptance of these procedures, which in turn drives the invisible orthodontics market.

The increasing dental healthcare expenditure has been contributing to the growth of the invisible orthodontics market. According to CMS, the spending on dental services increased by 3.2% to $129.1 Billion in 2017. While private health insurance increased by 2.8% in the same year, the out-of-pocket spending on dental services grew by 2.5% (accounting for 41% of dental spending).

For In-Depth Competitive Analysis, Buy Now @  https://www.persistencemarketresearch.com/checkout/13498

Company Profiles 

Dentsply Sirona

    • Straumann Group
    • Henry Schein, Inc.
    • ALIGN TECHNOLOGY, INC.
    • Danaher Corporation (Ormco)
    • TP Orthodontics, Inc.
    • American Orthodontics
    • DynaFlex
      • Bernhard Foerster GmbH
]]>
5.1% CAGR Is Marked In Arthroscopic Devices Market With The Value of Us $10 Bn By 2022 Mon, 27 Jan 2020 15:33:05 +0100 http://comunicati.net/comunicati/aziende/editoria/617192.html http://comunicati.net/comunicati/aziende/editoria/617192.html persistencemarketresearch persistencemarketresearch  

The global  arthroscopic devices market  is estimated to register a  CAGR of 5.1%  over the forecast period 2017 to 2022, according to a new report by  Persistence Market Research (PMR) . The market for arthroscopic devices has been witnessing a paradigm shift from conventional open surgeries to the minimally invasive ones, on the back of complications pertaining to the former.

Many governments around the world are taking initiatives associated with healthcare tourism via deals & packages, which includes easier visa approvals, and post-operation follow-ups. These factors will positively influence the market for arthroscopic devices globally. Revenues from the market are expected to exceed  US $ 1,700 Mn by 2022-end.

Patients Prefer Hospitals over Orthopedic Clinics & ASCs for Arthroscopic Procedures

Hospitals are expected to remain the largest end-users of arthroscopic devices in the global market. Most of the patients prefer hospitals for arthroscopic procedures over other healthcare settings such as orthopedic clinics, and ASCs. This is mainly because hospitals procure medical products, consumables, and accessories in bulk quantities, engaging closely with manufacturers & suppliers, government agencies, and reimbursement authorities

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/18358

.Among various products in the global arthroscopic devices market, arthroscopes are expected to remain the most lucrative, with sales anticipated to register an impressive expansion through 2022. The number of arthroscopic procedures is witnessing a significant surge, owing to the rise in older population worldwide.

In addition, requirement for accurate and early diagnosis of patient conditions have increased demand for cost-effective minimally-invasive procedures, such as arthroscopy. These factors are expected to spur demand for arthroscopes over the forecast period.

Arthroscopic Devices Market in APEJ to Gain Higher Traction During 2017 to 2022

The market in Asia-Pacific excluding Japan (APEJ) is poised to gain a significant traction over the forecast period, particularly in the region’s developing economies such as China and India. Existence of better insurance schemes, favorable reimbursements, low taxation, increased sports activity and related injuries, and rise in purchasing power of population in the region are key drivers for growth of the market in APEJ. Moreover the healthcare tourism in India and China is gaining popularity owing to a relatively lower expenditure requirement, and rising treatment success rates through use of technologically advanced systems.

This will further influence expansion of the arthroscopic devices market in APEJ. However, the markets in North America and Europe are expected to remain comparatively more lucrative, owing to presence of leading market players, and relatively higher healthcare tourism attraction.

For Critical Insights On The Arthroscopic Devices Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/18358

Knee Arthroscopy is expected to remain the largest application of arthroscopic devices, with revenues accounting for over one-third share of the market during 2017 to 2022. Hip arthroscopy will stick to its position of being the second most lucrative application of arthroscopic devices. Between spine arthroscopy and shoulder & elbow arthroscopy, the former will account for larger revenues, whereas the latter will exhibit a higher CAGR through 2022.

Company Profile

  • Arthrex, Inc.
  • Stryker Corporation
  • CONMED Corporation
  • Smith & Nephew
  • Zimmer Biomet Holdings, Inc
  • Medtronic Plc
  • Wright Medical Group N.V.
  • Stryker Corporation
  • Richard Wolf GMBH
  • Others

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/18358

Arthroscopy Taking Digital Leap towards Operation Theatre Customization

High-volume commoditization of arthroscopic devices, owing to their constant replacement, is creating a steady revenue stream for medical device manufacturers. Various technological advancements are have been witnessed in arthroscopic devices since recent past.

For instance, Zimmer Biomet introduced “Vanguard” in 2016, which revolutionized the total knee replacement procedure. In addition, a slew of innovations in arthroscopy visualization systems, such as development of high, and ultra-high definition systems providing an enhanced video quality, have facilitated visualization of patients’ anatomy. Lower risk of infections associated with the arthroscopy procedures, coupled with faster recovery time of patients and rapid results obtained by the procedures are expected to propel demand for arthroscopic devices.

Utilizing standardized imaging systems, arthroscopy has taken a digital leap to customized operation theaters, which have integrated fluid management systems, power instruments, cameras, and endoscopes. This will further influence demand for arthroscopic devices in the years to come.

]]>
15.2% CAGR Is Marked In Proton Therapy Systems Market With The Value of US$ 3,000 Mn By 2024 Mon, 27 Jan 2020 15:32:42 +0100 http://comunicati.net/comunicati/aziende/editoria/617191.html http://comunicati.net/comunicati/aziende/editoria/617191.html persistencemarketresearch persistencemarketresearch

Growing prevalence of cancer has prompted medical organizations towards development and adoption of advanced treatment procedures, such as proton radiotherapy. The effectiveness of proton therapy continues to gain trust of cancer patients across the globe.

The procedure is known for successfully destructing tumor cells by damaging their DNA through a targeted deposition of high-energy radiation dosage onto the tumor. Furthermore, doctors treating cancer patients are also benefiting from the feasibility of proton therapy as it can be used in conjunction with other treatments.

Factors as such continue to promote the adoption of proton therapy for curing cancerous abnormalities. Persistence Market Research projects that by the end of 2024, the global market for proton therapy will bring in more than US$ 2,926.7 Mn in revenues.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/12358

In the report, titled “Proton Therapy Market: Global Industry Analysis and Forecast, 2016-2024,” the global market for proton therapy is presently valued at closed to US$ 945 Mn and is projected to soar at a healthy CAGR of 15.2%. The report estimates that governments from all corners of the globe will continue to shore up their healthcare expenditure on cancer care facilities, which will incidentally boost the revenues in global proton therapy market. Additional benefits of availing proton therapy, compared to chemotherapy or radiation therapy, will also instrument a steadfast revenue growth for the market.

Based on a regional analysis compiled in the report, North America is projected to account for a little less than one-third share of global proton therapy revenues throughout the forecast period. However, Europe’s proton therapy market will dominate with close to 38% share and showcase revenue growth at 15.7% CAGR. The report has also profiled leading players in the global proton therapy market,

For Critical Insights On The Proton Therapy Systems Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/12358

Company Profiles

  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • ProNova Solutions, LLC
  • ProTom International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems
  • Others

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/12358 

Key highlights of the research report on global proton therapy market follow:

  • The market is likely to benefit from companies manufacturing compact set up used in proton beam therapy, which help in saving production costs without impairing product efficacy
  • Based on such set ups, multiple-room proton therapy will gain traction by accounting for more than three-fourth of global revenues towards the end of forecast period
  • Among multiple cancer indications, the adoption of proton therapy will be relatively higher for treatment of lung cancer, gastro-intestinal cancer, pediatric cancer, head & neck cancer
  • Flexible payment options are also boosting the supply of proton therapy devices, while affordability of such devices continues to be a major challenge
  • The report also predicts that the demand for proton therapy will be impacted by the therapy's side-effects which includes fatigue, skin irritation, swelling and skin blistering
  • Nonetheless, the market will witness opportunistic growth in terms of rising preference to non-invasive treatment of cancerous tumors
]]>
7.9% CAGR Is Marked In Medical And Industrial Gloves Market With The Value of US$ 12,868.6 Mn By 2026 Mon, 27 Jan 2020 15:32:19 +0100 http://comunicati.net/comunicati/aziende/editoria/617190.html http://comunicati.net/comunicati/aziende/editoria/617190.html persistencemarketresearch persistencemarketresearch

Persistence Market Research has estimated the global market for medical & industrial gloves at  US $ 12,868.6 Mn by the end of 2026 , exhibiting robust expansion at a  CAGR of 7.9% over 2018–2026 . According to the latest market outlook released by the company, the global  Medical & Industrial Gloves Market  holds promising growth prospects over the next eight years.

The market will benefit from multiple innovations through intense research and development efforts initiated by hospitals and research centers, as well as medical research institutes, in near future.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/23506

Low-cost Antimicrobial Medical Gloves Launched in London; Worldwide Launch Plans in Pipeline

A revolutionary type of medical examination glove has been developed recently, which seems to have an entire new layer of infection control. These gloves are designed to have the built-in antimicrobial technology, which has already been evident of preventing the spread of infection in highly sensitive areas such as hospitals. A microbiologist, and a professor by profession in the University of Nottingham, has been working for more than six years on the research and development of infection-preventing medical examination gloves.

The researcher has been working with a few professionals from the Malaysian glove making giant Hartalega Malaysia, and the antimicrobial research and development company Chemical Intelligence UK.

The non-leaching antimicrobial technology that has been used in the trials refers to as “a new active microorganism-killing molecule.” The infection-preventing medical gloves are claimed to be possessing an active molecule that has the capability to kill microorganisms, which has been specifically designed to prevent the spread of bacterial infection, to and from surfaces and people.

For Critical Insights On The Medical And Industrial Gloves Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/23506

Since the infection-controlling technology has been built into the material, it offers an additional advantage of not requiring any surface applications of any solutions or chemicals, before use. It has been claimed by the resources involved in the trial for these medical gloves that these gloves recorded nearly 99.9% bacterial killing during independent testing.

Experts are expecting the antimicrobial medical gloves to directly translate the life science into a practical tool that will potentially hold an immense impact on the global market for medical and industrial gloves. These gloves are likely to be initially available in hospitals worldwide, and the manufacturing partners are anticipated to assure lower cost of these product, chiefly to prevent barriers to access.

Company Profile

  • Ansell
  • Comfort Rubber Gloves Industries Sdn Bhd
  • Top Glove Corporation Bhd
  • Rubberex
  • Cardinal Health, Inc.
  • B.Braun Melsungen AG
  • Kossan Rubber Industries Bhd
  • Semperit AG Holding
  • Hartalega Holdings Berhad
  • Supermax Corporation Berhad.
  • Others.

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/23506

PMR’s Global Medical & Industrial Gloves Market Report: Key Takeaways

  • Increase in number of surgeries and growing number of end-users are some of the driving factors for the medical & industrial gloves market. However, increasing disposable waste and environmental damage restrain the market growth.
  • North America and Europe occupy more than 80% of the Medical & Industrial Gloves Market. In recent years, rise in cases of hospital acquired infection are reported in in North America.
  • In terms of end users, the medical sector accounts for maximum revenue in the Medical & Industrial Gloves Market due to increased usage of gloves in acute care, laboratory services, and research services.
  • Ban of powdered gloves and growing reuse of disposable gloves are some of the challenges observed in the medical & industrial gloves marketplace, expected to hamper market growth.
  • Disposable Examination Gloves is the most common product that is commercially available.
]]>
5.4% CAGR Is Marked In Next Generation IV Infusion Pumps Market With The Value of US$ 3.2 Bn By 2025 Mon, 27 Jan 2020 15:31:57 +0100 http://comunicati.net/comunicati/aziende/editoria/617189.html http://comunicati.net/comunicati/aziende/editoria/617189.html persistencemarketresearch persistencemarketresearch

Persistence Market Research has carried out a detailed market research on next-generation IV infusion pumps and has presented vital insights based on the market analyzes in its research publication titled  "Next-Generation IV Infusion Pumps Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025) ". 

This research report covers various macro-economic aspects influencing the growth of the next generation IV infusion pumps market along with various trends, opportunities, restraints and drivers impacting the market. These impacting factors are scrutinized across important regions considering all major market segments.

Global Next-Generation IV Infusion Pumps Market: Forecast

The global  next-generation IV infusion pumps market  has been thoroughly analyzed and is anticipated to grow at a robust  CAGR of 5.4%  throughout the period of forecast 2017-2025. The global market is estimated to reach a value of about  US $ 3.2 Bn in 2025  from a value of around  US $ 2 Bn in 2016 . This market has witnessed a positive growth path since 2012 and it is poised to continue over the following years.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/15781

Global Next-Generation IV Infusion Pumps Market: Dynamics

Expanding production base for smart PCA, ambulatory and syringe pumps in developing economies and rising adoption of smart pumps with huge drug libraries are opportunities that can be tapped by players involved in the global next-generation IV infusion pumps market. Emerging economies offer high opportunities as they register high rate of spread of chronic diseases.

The advancements in IV infusion pumps systems, increasing research and development infrastructure due to rising investments and expenditure on research and development, favorable reimbursement for infusion therapy, rising demand for ambulatory infusion pumps, increasing strategic collaborations among leading players, improvement in distribution channel, ease in FDA approvals and clearance, strong government support for start-ups, expanding production capacity and extension of product line coupled with expanding medical device infrastructure and growing adoption of advanced medical devices have strongly supported the growth of the next-generation IV infusion pumps market.

For Critical Insights On The Next Generation Iv Infusion Pumps Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/15781

Medicine dispensing errors, product recalls due to product errors, lack of skilled personnel and lack of standard usage guidelines are few aspects which pull the adoption of next-generation IV infusion pumps thus having a negative impact on the global next-generation IV infusion pumps market.

Global Next-Generation IV Infusion Pumps Market: Segmental Highlights

The global next-generation IV infusion pumps market has been categorized by product type, by application, by end user and by region.

  • By region, Asia Pacific is expected to witness high growth as compared to other regions, and is poised to reach a significant market share with a high CAGR of 7.8% throughout the period of forecast 2017-2025. North America region stays ahead with respect to market value to dominate the global next-generation IV infusion pumps market by region followed by Europe
  • Chemotherapy segment by application is the fastest growing segment and is expected to reflect high market valuation by the end of 2025. This segment is projected to grow at a CAGR of 7.1% throughout the forecast period to attain an estimated value of about US$ 1.1 Bn in 2025
  • Hospitals segment by end user dominates the global market and also poised to reflect a high CAGR of 6.0% during the assessment period due to rise in adoption of infusion pumps in hospitals
  • Large volumetric infusion systems to lead the global next-generation IV infusion pumps market by product type to reach a market value of about US$ 1.1 Bn in 2025. Electronic ambulatory infusion systems product segment is poised to show high potential in the coming years

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/15781

Global Next-Generation IV Infusion Pumps Market: Competitive Landscape

Company Profiles

  • B. Braun Melsungen AG. 
  • Becton, Dickinson Company 
  • Fresenius Kabi AG 
  • Terumo Corporation 
  • Medtronic Plc. 
  • Baxter International Inc. 
  • Hospira, Inc. 
  • iRadimed Corporation
  • Zyno Medical
  • Nipro Corporation 
  • Ambu A / S 
  • Summit Medical Products, Inc.
  • Smiths Medical 
  • vTitan
  • Gamastech srl
  • Others.
]]>
4.4% CAGR Is Marked In Antibody Library Technology Market With The Value of US$ 100 Mn By 2024 Mon, 27 Jan 2020 15:31:35 +0100 http://comunicati.net/comunicati/aziende/editoria/617188.html http://comunicati.net/comunicati/aziende/editoria/617188.html persistencemarketresearch persistencemarketresearch  

Demand for antibody library technologies is expected to surge, as the arrival of advanced antibodies and their display technologies continue to reduce complexities of life science and biotechnology research.

Persistence Market Research (PMR), in its latest report, projects that the global  antibody library technologies market  revenue will increase at a  CAGR of 4.4% between 2016 and 2024 . Some of the latest antibody library design and selection methods enable easy identification of any MAB with any specificity, which is why pharmaceutical companies are increasingly making use of such technologies in their facilities.

"Owing to the limitation and shortcomings of the conventional molecular display technologies, medical research organizations are now shifting towards new age display less' technologies, capable of isolating antibodies up to subnanomolar affinities." - Analyst,  Persistence Market Research

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/11155

Global Antibody Library Technologies: Key Market Trends

  • As the market becomes more competitive, players aim to offer additional services complementary to antibody libraries.
  • Consolidation between technology developers and drug development organizations in order to increase the consumer base has been identified as a prominent trend in the global market for antibody library technologies.
  • Widespread adoption of cell-free display platform will persist throughout the forecast period, owing to the compact nature of such contemporary display platforms. For instance, the popularity of cell-free ribosome display technology has grown significantly amongst end-users in recent years.

For Critical Insights On The Antibody Library Technology Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/11155

Highlights of the Report Include

Phage display to remain as the predominant antibody library technology in 2017 and beyond. Moreover, constant technological advancement is expected to support its widespread adoption in the medium term. Phage display was the first in vitro technology developed for antibody selection and is extensively used by scientists all over the world. In 2016, sales revenue of phage display technology reached US$ 68.0 Million and is likely increase at 5% CAGR over 2024. Based on application, antibody library technologies are primarily used in drug discovery programs.

Nearly US$ 81.3 Million worth antibody library technologies were purchased for drug development purposes in 2016. Meanwhile, biopharmaceutical companies remain the major end users of such technologies and are expected to create an incremental opportunity of US$ 44.Mn between 2016 and 2026 for the market.

Amongst all the key regions, the antibody library technologies market in North America accounted for a massive revenue share of 57.5% in 2015. This is primarily due to the favorable government initiatives for development of cost-effective monoclonal antibodies in the US, which is driving the demand for antibody library technologies in the region. North America will continue to be most lucrative market over the forecast period followed by Europe and APAC.

For In-Depth Competitive Analysis, Buy Now @   https://www.persistencemarketresearch.com/checkout/11155

Company Profiles

  • MorphoSys AG
  • Dyax Corp.
  • Abzena Plc.
  • XOMA Corporation
  • AvantGen Inc.
  • Creative-Biolabs
  • AbCheck sro
  • Philogen SpA
  • Adimab LLC
  • Invenra Inc.
  • AnaptysBio, Inc.
  • Abwiz Bio Inc.
  • Abgent Inc. (WuXi AppTec company)
  • Vaccinex Inc.
  • AxioMx Inc.
  • Others
]]>
5.8% CAGR Is Marked In DNA RNA Sample Preparation Market With The Value of US$ 440 Mn By 2025 Mon, 27 Jan 2020 15:31:13 +0100 http://comunicati.net/comunicati/aziende/editoria/617187.html http://comunicati.net/comunicati/aziende/editoria/617187.html persistencemarketresearch persistencemarketresearch

DNA and RNA sample preparation provides accessibility to nucleic acids in natural form, removing unwanted contaminants. The process of DNA and RNA sample preparation has become highly refined. Multi-national companies are actively focusing on the development of faster and accurate products, which includes workstations, kits, and reagents & consumables. Persistence Market Research (PMR), in its report titled, " DNA and RNA Sample Preparation Market : Global Industry Analysis and Forecast, 2017-2025 " has provided a detailed analysis of the global DNA and RNA sample preparation market.

Kits Product-type Segment Expected to Hold Largest Market Share

PMR estimates that kits for DNA and RNA sample preparation would account for around 60% market share in 2017. However, this product type segment is expected to witness a slight decline in its market share by 2025-end. Although kits will experience a decline in their market share, they are estimated to hold the largest market share in the global DNA and RNA sample preparation market during the forecast period. Workstations are expected to exhibit the fastest growth at 5.8% CAGR through 2025.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/3211

Soaring Demand for Modern Extraction Techniques Estimated to Drive Market Growth

The global DNA and RNA sample preparation market is projected to register a steady growth at 5.5% CAGR during the forecast period. The US$ 1,293.6 Mn market is estimated to reach US$ 2,090.2 Mn through 2025. Investment in basic research, particularly by academic & research institutes, since past several years have led to solid understanding of fundamental pathways.

Through this, various proteins implicated in disease development are either up-regulated or down-regulated. In addition, growing requests by researchers for complex products is an evidence of improvement in understanding basic pathways and discovering new pathways. These factors lead to greater knowledge of cellular pathways, which in turn are estimated to fuel the demand for DNA and RNA sample preparation in the near future.

For Critical Insights On The Dna Rna Sample Preparation Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/3211

Technological advancements in nucleic acid preparation processes have driven a greater demand for high quality kits, reagents, and associated products. Technological advancements in the methods of DNA and RNA sample preparation, global agreement between leading research institutes for boosting research activities in molecular biology field, soaring demand for modern extraction techniques, and technological advancements in analytical instruments are some major factors driving the market growth.

However, increasing inclination of preferences for premium products, owing to their higher quality as compared to standard reagents and products, is expected to restrain the growth of the global DNA and RNA sample preparation market.

Hospitals to be Second-most Lucrative End User by 2025-End

Academic and research institutes are expected to be the most lucrative end user in the global DNA and RNA sample preparation market through 2025. This segment is expected to  exhibit 5.9% CAGR  during the forecast period. Hospitals are expected to be the second most lucrative end user segment in the overall market. Based on applications, research applications are expected to remain dominant in the global DNA and RNA sample preparation market during the forecast period. Clinical testing, following research applications, are expected to  exhibit 5.4% CAGR through 2025 .

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/3211 

Asia Pacific to Register a CAGR similar to North America

Company Profiles

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc. 
  • DiaSorin SpA
  • F. Hoffmann-La Roche
  • Illumina, Inc.
  • PerkinElmer, Inc. 
  • QIAGEN
  • Sigma Aldrich Corp. 
  • Tecan Group AG. 
  • Thermo Fisher Scientific, Inc. 
  • Others
]]>
5.6% CAGR Is Marked In Dental CAD CAM Dental Prosthesis Market With The Value of US$ 14,528.6 Mn By 2026 Mon, 27 Jan 2020 15:30:51 +0100 http://comunicati.net/comunicati/aziende/editoria/617186.html http://comunicati.net/comunicati/aziende/editoria/617186.html persistencemarketresearch persistencemarketresearch

Persistence Market Research delivers the key insights on the global dental CAD / CAM & dental prosthesis market in its upcoming report titled "Dental CAD / CAM & Dental Prosthesis Market: Global Industry Analysis 2013–2017 and Forecast 2018 - 2026". In terms of revenue, the global  dental CAD / CAM & dental prosthesis market  is projected to register a  CAGR of 5.6%  over the forecast period, owing to various factors, regarding which PMR offers detailed insights and forecast.

The dental CAD / CAM & dental prosthesis market is expected to record a year-over-year  growth rate of 5.6% by 2026 . The dental CAD / CAM & dental prosthesis market is segmented based on product type, end users and regions.

By  product type , the dental CAD / CAM & dental prosthesis market is segmented into; dental prosthesis and dental CAD / CAM system. Dental prosthesis is segmented into custom dental prosthesis which comprises of dental implants, dentures, crowns & bridges, inlays & onlays and others. And 3D Dental Prosthesis which comprises of ceramic based, alloy based and others.

Dental CAD/CAM system is segmented into chair-side system and laboratory system. The 3D Dental Prosthesis is expected to account a high share in the dental CAD/CAM & dental prosthesis market, with a growth rate of 5.7% by 2026. The laboratory system segment is expected to witness sluggish growth in the global dental CAD/CAM & dental prosthesis market due to already penetrated market space.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/24610

The growth of the dental CAD/CAM & dental prosthesis market is related to the dental industry which would benefit a lot from the ongoing production change using digital method. As the technology continues to advance traditional methods, it betters the further improvement in treatments and outcomes coming out of digital manipulation.

3D printing is the most ideal solution which incurs cost that is simply there in other method and ideally helps the entire dental industry to have a cut shot in their spending and with higher production rate and waste control tends the manufacturers to have a better take at generating higher revenue. 3D printing is shifting from prototyping to production

The reach for dental CAD/CAM & dental prosthesis market to match the disposable income of the middle-class population across the globe has led to changing customer approach towards dental treatment. Products are more furiously accepted in emerging markets as they are cost-effective and offer good quality which suits the present condition and certain points of reimbursements policies for dental CAD/CAM & dental prosthesis which somehow shifts with regional influence marks as a trend that is being followed and visible in emerging regions.

It is an emerging opportunity for manufacturers to provide in-clinic systems to clinics in order to produce dental prosthetics, which is going to save ample time in building a prosthetic, makes the entire process less expensive, provide a more precise finishing and easy working condition. 3D dentistry is well on its verge to become the new standard of dental care.

Most of the dental caries are objective to school going children and is supposedly taken care by the dentists in major high income countries. But the question arises when middle and low income countries are surveyed, a different trend of cases are reported there. As there is a relative high no. cases in North America and in the European region; the count is somewhere less in Western Pacific and Eastern Mediterranean and for it is less severe in South East Asia and Africa. Also, in Africa, the dentist to population ratio is approx. 1:150,000 against most industrialized countries reported by WHO in 2009

For Critical Insights On The Dental Cad Cam Dental Prosthesis Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/24610

The dental prosthesis segment is estimated to witness significant growth in the global dental CAD/CAM & dental prosthesis market with both custom dental prosthesis and 3D dental prosthesis products available. The 3D dental prosthesis market is most certain to have a higher impact in the overall dental CAD/CAM & dental prosthesis market with products of ceramic based, alloy based and others offered in the segment.

The dental CAD/CAM system is estimated to have a high growth in the global dental CAD/CAM & dental prosthesis market. With chair-side CAD/CAM system expected to have a higher growth rate over the forecast due to its versatility, scalable solution for different indications, speed, productivity, accuracy, repeatability, durability and reduced total cost of operations.

This report assesses the trends that are driving the growth of each segment on the global as well as regional level, and offers potential takeaways that could prove substantially useful for the manufacturers planning to enter the market.

Geographically, the global dental CAD/CAM & dental prosthesis market is segmented into North America, Europe, Latin America, Asia Pacific excluding China and Middle East & Africa. This report assesses the trends driving each segment and offers analysis and insights of the dental CAD/CAM & dental prosthesis market in specific regions.

Europe is expected to account major share in the global dental CAD/CAM & dental prosthesis market and is expected to grow at a CAGR of 5.8%. APEC is expected to have the highest growth rate for the global dental CAD/CAM & dental prosthesis market during the forecast period due to growing number of cases and improved healthcare infrastructure.

Company Profiles

  • 3M
  • VOCO GmbH.
  • COLTENE Group
  • DENTSPLY SIRONA INC
  • Den-Mat Holdings, LLC.
  • ENVISIONTEC, INC
  • Ivoclar Vivadent AG
  • Noble Biocare (Danaher)
  • Shofu
  • Dental Wings (Straumann group)
  • Others.

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/24610

In this report, we have discussed the individual strategies followed by these companies regarding the improvements in their products, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report has been concluded with key takeaways for players already present in the market and new players planning to enter the dental CAD/CAM & dental prosthesis market.

]]>
7% CAGR Is Marked In Stair Lifts Market With The Value of US$ 1,000 Mn By 2024 Mon, 27 Jan 2020 15:30:28 +0100 http://comunicati.net/comunicati/aziende/editoria/617185.html http://comunicati.net/comunicati/aziende/editoria/617185.html persistencemarketresearch persistencemarketresearch  

The global  stair lifts market  is anticipated to expand at a  CAGR of 7%  during the forecast period 2016-2024. Europe will remain the largest market, while North America will grow at the fastest rate during the forecast period.

Ease of accessibility and low installation costs are the key factors driving the growth of the stair lifts market. Moreover, the rise in geriatric population and aging-related health conditions, such as osteoarthritis is also accelerating the demand for stair lifts. High level of mobility and user-friendliness is considered to be a top feature of stair lifts.

In addition, the quick premarket approval process is expected to play a key role in pushing the demand for stair lifts during the forecast period.

High prices and negative customer reviews regarding the post-sales service are longstanding challenges in the stair lift market. In addition, concerns regarding the potential risk of injury owing to inappropriate installation will continue to pose challenges to growth.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/5621

Owing to their numerous advantages, various government and private organizations are looking to invest in star lifts, and this is expected to create growth opportunities for manufacturers during the forecast period. Implementation of latest technology to enhance safety is expected to increase confidence among consumers, thereby, bolstering demand during the forecast period.

Incorporation of adaptive technology, such as manual and powered Swivel technology along with a safety switch is a key trend among manufacturers. Another key trend in the stair life market is the use of rechargeable batteries which has led to simplified operations and high efficiency.

Europe will remain the numero uno market for stair lifts during the forecast period 2016-2024. The Europe stair life market is expected to reach US$ 396 Mn by the end of 2016 and witness a CAGR of 7.2% through 2024.

For Critical Insights On The Stair Lifts Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/5621

Strong distribution strategy and unparalleled product innovation will primarily drive the European stair lifts market. The UK, Germany, and France are expected to retain their position as the top 3 markets in Europe during the forecast period, with the UK stair lifts market expected to surpass US$ 167 Mn in 2016.

North America will remain the second largest market for stair lifts, with overall demand dominated by the US. Innovative products and quicker premarket approvals are expected to play a key role in driving the growth of the North America stair lift market.

Moreover, increased awareness about stair lifts among patients with disabled mobility is also expected to fuel demand during the forecast period. In the backdrop of these factors, the North America stair lift market is anticipated to reach US$ 284.9 Mn in 2016.

Asia Pacific, the third largest market for stair lifts, is expected to witness impressive growth during the forecast period. The APAC stair lift market is expected to grow by 5% in terms of revenues in 2016. Japan is expected to remain the largest market during the forecast period, followed by China.

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/5621

Company Profiles

  • Acorn Stairlifts Inc.
  • Stannah International
  • Savaria Corp.
  • Handicare Group AB
  • Lehner Lifttechnik GmbH
  • Otolift Stairlifts Ltd.
  • Harmar Mobility LLC
  • Prism U.K. Medical Limited
  • Bruno Independent Living Aids, Inc.
  • Platinum Stair Lifts Ltd.
  • HIRO LIFT (Hillenkötter + Ronsieck
  • Kumalift Co., Ltd.
  • SUGIYASU Co., Ltd.
  • Symax Lift (China) Co, Ltd.
  • Qingdao Sinofirst Machinery Co., L
  • Taamal Seed Electra Group
  • Millepiani Spa Group
  • Others
]]>
4.1% CAGR Is Marked In Urinary Catheters Market With The Value of US$ 387.2 Mn By 2021 Mon, 27 Jan 2020 15:27:02 +0100 http://comunicati.net/comunicati/aziende/editoria/617184.html http://comunicati.net/comunicati/aziende/editoria/617184.html persistencemarketresearch persistencemarketresearch
According to a new market report published by Persistence Market Research titled " Global Market Study on Urinary Catheters:  Intermittent Catheters Segment to Witness Highest Growth by 2021", the  urinary catheters market  is expected to be  valued at US $ 1,377.5 Mn by the end of 2015 . It is anticipated to expand at a  CAGR of 4.1% from 2015 to 2021 , to  reach US $ 1,755.0Mn by 2021 .
 
Presently, the urinary catheter market is mainly driven by factors such as growing aging population, favorable reimbursement policies and increasing demand for advanced urinary catheters.
 
To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/3268
However, factors such as growing incidence of urinary tract infections and the threat from substitutes are expected to hamper market growth. The urinary catheter market is segmented on the basis of product type and application.
 
The global catheter market was valued at  around US $ 25,895.6Mn 2014 . The urinary catheter market accounted for 5.1% of global catheter market in 2014 and was  valued at US $ 1,326.0 million . Revenue contribution by urinary catheter market to the global catheter market is expected to  increase to US $ 1,755.0 by the end of 2021 expanding at a CAGR of 4.1% between 2015 and 2021 .
 

For Critical Insights On The Urinary Catheters Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/3268

 
The increasing prevalence of chronic diseases and growing ageing population are factors expected to positively affect the growth of the urinary catheter market across the globe.
 
By region, North America dominated the market with over 30% market share and is expected to remain dominant throughout the forecast period. The urinary catheter market in Asia and Latin America are expected to expand at a CAGRs of 4.7% and 4.6% respectively during the forecast period.
 

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/3268

Company Profile

  • Boston Scientific Corporation
  • Medtronic plc. 
  • Hollister Incorporate 
  • B. Braun Melsungen AG
  • Coloplast A/S
  • Becton, Dickinson and Company
  • Teleflex Incorporation
  • Cook Medical

 

]]>
6.5% CAGR Is Marked In Cryotherapy Market With The Value of US$ 1500 Mn By 2024 Mon, 27 Jan 2020 15:26:40 +0100 http://comunicati.net/comunicati/aziende/editoria/617182.html http://comunicati.net/comunicati/aziende/editoria/617182.html persistencemarketresearch persistencemarketresearch  

According to a study conducted by Persistence Market Research (PMR), the global market for cryotherapy is set to witness a  CAGR of 6.5%  during the forecast period 2016-2024. According to the study, North America will continue to be the leading market for cryotherapy globally during the forecast period.

Highlights from the Report

  • Suppliers are emphasizing on ensuring affordable and adequate supply of gas in order to provide smoother maintenance services to clients, while steadily increasing the range of non-gas equipment.
  • Higher investments in training programs on cryosurgical approach are anticipated to broaden the pool of skilled resources / surgeons.

While growing popularity of minimally invasive procedures is propelling the demand for cryosurgery equipment, lack of information on treatment option and complex regulatory nature of cryosurgery equipment is likely to curb the overall market growth.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/12751

On the other side, higher success ratio of cryotherapy and availability of affordable treatment is expected to drive the growth of the global cryotherapy market over the forecast period. In addition, robust adoption the by sports and athletes associations and favorable reimbursement policies are influencing the overall market to expand at a pronounced rate.

Likewise, increasing strategic partnerships between healthcare associations and sports bodies is identified as a major trend governing the market. Moreover, factors such as fragmented nature of the market and presence of a handful of established player and many local vendors are expected to play a major role in shaping the market in the near future.

Market Overview

Based on products type, demand for cryochambers will remain strong during the assessment period, surging at a compound annual growth rate of nearly 7% over 2024. Expansion of production capacity would render the segment achieve market exclusivity.

Based on application, in 2016, the oncology segment was estimated to account for nearly 80% share of the market in terms of value. The segment is expected to witness a steady growth during the forecast period. Whereas, dermatology is expected to be the fastest growing segment, reflecting a CAGR of over 7% with an incremental opportunity of US$ 76.1 Million between 2016 and 2024.

For Critical Insights On The Cryotherapy Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/12751

By end user, hospitals are projected to be the fastest growing segment of the market. In addition, the segment is set to ride on a CAGR on 6.8% to reach US$ 2,479.3 Million by the end of 2024.

Regional Highlights

North America holds the lion’s share of global cryotherapy market partly due to the robust adoption of cryotherapy in healthcare, cosmetic, and wellness industry in the region. Europe is the second largest market for cryotherapy. In addition, the region is expected to rake in over US$ 1,001 Million in revenue by the end of the assessment period, with the UK, Germany and France being the top three attractive markets.

Whereas, APAC sits in the third position and is expected to contest for a higher position in the global market owing to the incessant installation of cryochambers and cryosurgical equipment in countries such as Japan, China, and Australia.

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/12751

Competitive Dashboard

Company Profiles

  • Zimmer MedizinSysteme GmbH 
  • Erbe Elektromedizin GmbH 
  • Impact Cryotherapy Inc. 
  • KrioSystem Sp. z.o.o 
  • The Cooper Companies Inc. 
  • Air Products and Chemicals, Inc. 
  • METRUM CRYOFLEX Sp. z o.o., Sp. K. 
  • Novotech S.R.O 
  • Others
]]>
4.1% CAGR Is Marked In Urinary Catheters Market With The Value of US$ 387.2 Mn By 2021 Mon, 27 Jan 2020 15:25:46 +0100 http://comunicati.net/comunicati/aziende/editoria/617180.html http://comunicati.net/comunicati/aziende/editoria/617180.html persistencemarketresearch persistencemarketresearch
According to a new market report published by Persistence Market Research titled " Global Market Study on Urinary Catheters:  Intermittent Catheters Segment to Witness Highest Growth by 2021", the  urinary catheters market  is expected to be  valued at US $ 1,377.5 Mn by the end of 2015 . It is anticipated to expand at a  CAGR of 4.1% from 2015 to 2021 , to  reach US $ 1,755.0Mn by 2021 .
 
Presently, the urinary catheter market is mainly driven by factors such as growing aging population, favorable reimbursement policies and increasing demand for advanced urinary catheters.
 
To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/3268
However, factors such as growing incidence of urinary tract infections and the threat from substitutes are expected to hamper market growth. The urinary catheter market is segmented on the basis of product type and application.
 
The global catheter market was valued at  around US $ 25,895.6Mn 2014 . The urinary catheter market accounted for 5.1% of global catheter market in 2014 and was  valued at US $ 1,326.0 million . Revenue contribution by urinary catheter market to the global catheter market is expected to  increase to US $ 1,755.0 by the end of 2021 expanding at a CAGR of 4.1% between 2015 and 2021 .
 

For Critical Insights On The Urinary Catheters Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/3268

 
The increasing prevalence of chronic diseases and growing ageing population are factors expected to positively affect the growth of the urinary catheter market across the globe.
 
By region, North America dominated the market with over 30% market share and is expected to remain dominant throughout the forecast period. The urinary catheter market in Asia and Latin America are expected to expand at a CAGRs of 4.7% and 4.6% respectively during the forecast period.
 

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/3268

Company Profile

  • Boston Scientific Corporation
  • Medtronic plc. 
  • Hollister Incorporate 
  • B. Braun Melsungen AG
  • Coloplast A/S
  • Becton, Dickinson and Company
  • Teleflex Incorporation
  • Cook Medical

 

]]>
6.5% CAGR Is Marked In Cryotherapy Market With The Value of US$ 1500 Mn By 2024 Mon, 27 Jan 2020 15:25:24 +0100 http://comunicati.net/comunicati/aziende/editoria/617179.html http://comunicati.net/comunicati/aziende/editoria/617179.html persistencemarketresearch persistencemarketresearch  

According to a study conducted by Persistence Market Research (PMR), the global market for cryotherapy is set to witness a  CAGR of 6.5%  during the forecast period 2016-2024. According to the study, North America will continue to be the leading market for cryotherapy globally during the forecast period.

Highlights from the Report

  • Suppliers are emphasizing on ensuring affordable and adequate supply of gas in order to provide smoother maintenance services to clients, while steadily increasing the range of non-gas equipment.
  • Higher investments in training programs on cryosurgical approach are anticipated to broaden the pool of skilled resources / surgeons.

While growing popularity of minimally invasive procedures is propelling the demand for cryosurgery equipment, lack of information on treatment option and complex regulatory nature of cryosurgery equipment is likely to curb the overall market growth.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/12751

On the other side, higher success ratio of cryotherapy and availability of affordable treatment is expected to drive the growth of the global cryotherapy market over the forecast period. In addition, robust adoption the by sports and athletes associations and favorable reimbursement policies are influencing the overall market to expand at a pronounced rate.

Likewise, increasing strategic partnerships between healthcare associations and sports bodies is identified as a major trend governing the market. Moreover, factors such as fragmented nature of the market and presence of a handful of established player and many local vendors are expected to play a major role in shaping the market in the near future.

Market Overview

Based on products type, demand for cryochambers will remain strong during the assessment period, surging at a compound annual growth rate of nearly 7% over 2024. Expansion of production capacity would render the segment achieve market exclusivity.

Based on application, in 2016, the oncology segment was estimated to account for nearly 80% share of the market in terms of value. The segment is expected to witness a steady growth during the forecast period. Whereas, dermatology is expected to be the fastest growing segment, reflecting a CAGR of over 7% with an incremental opportunity of US$ 76.1 Million between 2016 and 2024.

For Critical Insights On The Cryotherapy Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/12751

By end user, hospitals are projected to be the fastest growing segment of the market. In addition, the segment is set to ride on a CAGR on 6.8% to reach US$ 2,479.3 Million by the end of 2024.

Regional Highlights

North America holds the lion’s share of global cryotherapy market partly due to the robust adoption of cryotherapy in healthcare, cosmetic, and wellness industry in the region. Europe is the second largest market for cryotherapy. In addition, the region is expected to rake in over US$ 1,001 Million in revenue by the end of the assessment period, with the UK, Germany and France being the top three attractive markets.

Whereas, APAC sits in the third position and is expected to contest for a higher position in the global market owing to the incessant installation of cryochambers and cryosurgical equipment in countries such as Japan, China, and Australia.

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/12751

Competitive Dashboard

Company Profiles

  • Zimmer MedizinSysteme GmbH 
  • Erbe Elektromedizin GmbH 
  • Impact Cryotherapy Inc. 
  • KrioSystem Sp. z.o.o 
  • The Cooper Companies Inc. 
  • Air Products and Chemicals, Inc. 
  • METRUM CRYOFLEX Sp. z o.o., Sp. K. 
  • Novotech S.R.O 
  • Others
]]>
6.5% CAGR Is Marked In Cryotherapy Market With The Value of US$ 1500 Mn By 2024 Mon, 27 Jan 2020 15:25:01 +0100 http://comunicati.net/comunicati/aziende/editoria/617178.html http://comunicati.net/comunicati/aziende/editoria/617178.html persistencemarketresearch persistencemarketresearch  

According to a study conducted by Persistence Market Research (PMR), the global market for cryotherapy is set to witness a  CAGR of 6.5%  during the forecast period 2016-2024. According to the study, North America will continue to be the leading market for cryotherapy globally during the forecast period.

Highlights from the Report

  • Suppliers are emphasizing on ensuring affordable and adequate supply of gas in order to provide smoother maintenance services to clients, while steadily increasing the range of non-gas equipment.
  • Higher investments in training programs on cryosurgical approach are anticipated to broaden the pool of skilled resources / surgeons.

While growing popularity of minimally invasive procedures is propelling the demand for cryosurgery equipment, lack of information on treatment option and complex regulatory nature of cryosurgery equipment is likely to curb the overall market growth.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/12751

On the other side, higher success ratio of cryotherapy and availability of affordable treatment is expected to drive the growth of the global cryotherapy market over the forecast period. In addition, robust adoption the by sports and athletes associations and favorable reimbursement policies are influencing the overall market to expand at a pronounced rate.

Likewise, increasing strategic partnerships between healthcare associations and sports bodies is identified as a major trend governing the market. Moreover, factors such as fragmented nature of the market and presence of a handful of established player and many local vendors are expected to play a major role in shaping the market in the near future.

Market Overview

Based on products type, demand for cryochambers will remain strong during the assessment period, surging at a compound annual growth rate of nearly 7% over 2024. Expansion of production capacity would render the segment achieve market exclusivity.

Based on application, in 2016, the oncology segment was estimated to account for nearly 80% share of the market in terms of value. The segment is expected to witness a steady growth during the forecast period. Whereas, dermatology is expected to be the fastest growing segment, reflecting a CAGR of over 7% with an incremental opportunity of US$ 76.1 Million between 2016 and 2024.

For Critical Insights On The Cryotherapy Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/12751

By end user, hospitals are projected to be the fastest growing segment of the market. In addition, the segment is set to ride on a CAGR on 6.8% to reach US$ 2,479.3 Million by the end of 2024.

Regional Highlights

North America holds the lion’s share of global cryotherapy market partly due to the robust adoption of cryotherapy in healthcare, cosmetic, and wellness industry in the region. Europe is the second largest market for cryotherapy. In addition, the region is expected to rake in over US$ 1,001 Million in revenue by the end of the assessment period, with the UK, Germany and France being the top three attractive markets.

Whereas, APAC sits in the third position and is expected to contest for a higher position in the global market owing to the incessant installation of cryochambers and cryosurgical equipment in countries such as Japan, China, and Australia.

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/12751

Competitive Dashboard

Company Profiles

  • Zimmer MedizinSysteme GmbH 
  • Erbe Elektromedizin GmbH 
  • Impact Cryotherapy Inc. 
  • KrioSystem Sp. Zoo 
  • The Cooper Companies Inc. 
  • Air Products and Chemicals, Inc. 
  • METRUM CRYOFLEX Sp. Z oo, Sp. K. 
  • Novotech SRO 
  • Others
]]>
5.3% CAGR Is Marked In Surgical Gowns Market With The Value of US$ 1,703.9 Mn By 2025 Mon, 27 Jan 2020 15:24:39 +0100 http://comunicati.net/comunicati/aziende/editoria/617177.html http://comunicati.net/comunicati/aziende/editoria/617177.html persistencemarketresearch persistencemarketresearch  

The global demand for surgical gowns continues to be on a high, owing to the increasing number of surgeries being carried out on a daily basis in hospitals across the globe. In an attempt to study the performance of the global  surgical gowns market , Persistence Market Research has recently published a new report titled  "Surgical Gowns Market: Global Industry Analysis and Forecast (2017–2025),"  which analyzes the global surgical gowns market and presents useful insights over an eight year period from 2017 to 2025.

One of the key observations of the report centers on the global awareness of Hospital Acquired Infections (HAIs) that is working in favor of the increasing adoption of surgical gowns, both by patients and surgeons. The report also presents insights into the trends likely to govern the market such as innovations by surgical gowns manufacturers in the fabric used to manufacture surgical gowns.

Global Surgical Gowns Market: Overview & Forecast

The surgical gowns market is witnessing significant growth owing to better healthcare infrastructure especially in developed regions such as North America and Europe. The developing countries in the Asia Pacific are likely to exhibit the highest growth rate in the global surgical gowns market, owing to a high rate of population growth across the region. Persistence Market Research estimates the global surgical gowns market to reach a  valuation of US $ 1,703.9 Mn by 2025  end from an  estimated US $ 1,123.0 Mn in 2017 , resulting in a  CAGR of 5.3% over the period of forecast .

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/17143

Global Surgical Gowns Market: Segmental Forecast

The global surgical gowns market is segmented on the basis of Product Type into Disposable and Reusable surgical gowns. The disposable segment is the largest among the product types, with a projected 71.4% market share by the end of 2025. The disposable surgical gowns segment is expected to represent an absolute $ opportunity of US$ 40.7 Mn in 2018 over 2017, also creating an incremental opportunity of US$ 580.9 Mn between 2017 and 2025.

The global surgical gowns market is segmented on the basis of End User into Hospitals, Clinics & Trauma Centers, and Ambulatory Surgical Centers. Hospitals will continue to dominate the global market in terms of value throughout the forecast period, growing from an estimated US$ 731.6 Mn in 2017 to US$ 1,113.9 Mn by the end of the forecast period in 2025, registering a CAGR of 5.4%. Ambulatory surgical centers will lead the market in terms of CAGR growth though, recording 6.0% during the forecast period.

The global surgical gowns market is segmented on the basis of Distribution Channel into Online Sales, Retail Pharmacies, and Direct Sales. Direct sales is the largest segment in this category, which is estimated to represent US$ 970.7 Mn, or 86.4% share of the total market in 2017 in terms of revenue and expanding at a CAGR of 5.5% over the forecast period. The direct sales distribution channel segment is expected to represent an absolute $ opportunity of US$ 48.5 Mn in 2018 over 2017, also creating an incremental opportunity of US$ 518.6 Mn between 2017 and 2025.

For Critical Insights On The Surgical Gowns Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/17143

Persistence Market Research has tracked the global surgical gowns market across the key Regions of North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America and Asia Pacific are the largest regional markets in the global surgical gowns market, with North America slated to hold a market share of almost 22% and Asia Pacific a share of 30% in the global market by the end of 2025.

The number of surgeries performed per year is the highest in North America and hence North America is expected to continue to generate maximum revenue in the global surgical gowns market. The Asia Pacific surgical gowns market will grow at 7.1% CAGR during the forecast period while North America will register the lowest regional CAGR of 3.3%.

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/17143  

Competition Dashboard

Company Profiles

  • Ahlstrom-Munksjö
  • Alan Medical
  • Cardinal Health, INC.
  • FULLSTAR NON-WOVEN PRODUCTS CO. LTD.
  • Garmex Andrzej Jafiszow, Wojciech Kaminski sp. J.
  • GrupA Medical Products
  • Halyard Health, Inc.
  • Hogy Medical Co. Ltd.
  • Johnson & Johnson
  • Lohmann & Rauscher GmbH & Co. KG
  • Medline Industries, Inc.
  • Molnlycke Health Care
  • NUREL MEDIKAL SANAYI VE TICARET ANONIM SIRKETI
  • Paul Hartmann AG
  • PRIMED Medical Products, Inc.
  • Priontex (PTY) LTD
  • Surgiene Healthcare (India) Pvt. Ltd.
  • TIDI Products LLC
  • Vygon SA
  • 3M Company
  • Others
]]>
10.3% CAGR Is Marked In Scar Treatment Market With The Value of US$ 13,106.0 Million By 2022 Mon, 27 Jan 2020 15:24:17 +0100 http://comunicati.net/comunicati/aziende/editoria/617176.html http://comunicati.net/comunicati/aziende/editoria/617176.html persistencemarketresearch persistencemarketresearch  

According to a new market report published by Persistence Market Research "Global Market Study on  Scar Treatment:  Asia to Witness Highest Growth by 2022", the global  scar treatment market  is estimated to account for  US $ 16,048.7 Mn  by the end of 2015. The market is expected to expand at a  CAGR of 10.3%  from 2015 to 2022, accounting for  US $ 31,904.8 Mn  by 2022.

The global scar treatment market is witnessing significant growth due to rising prevalence of skin disease and growing expenditure on personal care. Moreover, technological advancements in scar treatment and increasing appearance consciousness among consumers are also driving the growth of the market.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/3471

However, high costs of advanced scar treatments and side effects of various treatments inhibits the growth of the market. The scar treatment market is anticipated to grow from an estimated  US $ 16,048.7 Mn  in 2015 to  US $ 31,904.8 Mn  by 2022 at a  CAGR of 10.3%  during the forecast period.

In North America, the disposable income of people is high compared to other regions of the world, which results in high spending on personal care in the region. For instance, in 2014, around 10 million surgical and nonsurgical cosmetic procedures were performed in the US

In Europe, the scar treatment market is driven by high disposable income in the Western European region, rising awareness about scar treatments, appearance consciousness and increasing the prevalence of wounds in the region.

For Critical Insights On The Scar Treatment Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/3471

However, the growth of scar treatment market in Asia is much higher than that in developed countries, due to population explosion and improving healthcare facilities in the region. There are several other factors driving the scar treatment market in Asia such as rising disposable income, increasing the prevalence of skin related problems, and growing focus on personal well-being.

For In-Depth Competitive Analysis, Buy Now @  https://www.persistencemarketresearch.com/checkout/3471

Company Profiles

  • Merz Pharma GmbH & Co. KGaA
  • Pacific World Corporation
  • Oculus Innovative Sciences, Inc.
  • Valeant Pharmaceuticals International Inc.
  • Avita Medical Limited
  • Enaltus, LLC.
  • Revitol Corporation Inc.
  • Scarguard Labs LLC
  • Quantum, Inc.
  • CCA industries Inc
]]>
4.1% CAGR Is Marked In Urinary Catheters Market With The Value of US$ 387.2 Mn By 2021 Mon, 27 Jan 2020 15:23:55 +0100 http://comunicati.net/comunicati/aziende/editoria/617175.html http://comunicati.net/comunicati/aziende/editoria/617175.html persistencemarketresearch persistencemarketresearch
According to a new market report published by Persistence Market Research titled " Global Market Study on Urinary Catheters:  Intermittent Catheters Segment to Witness Highest Growth by 2021", the  urinary catheters market  is expected to be  valued at US $ 1,377.5 Mn by the end of 2015 . It is anticipated to expand at a  CAGR of 4.1% from 2015 to 2021 , to  reach US $ 1,755.0Mn by 2021 .
 
Presently, the urinary catheter market is mainly driven by factors such as growing aging population, favorable reimbursement policies and increasing demand for advanced urinary catheters.
 
To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/3268
However, factors such as growing incidence of urinary tract infections and the threat from substitutes are expected to hamper market growth. The urinary catheter market is segmented on the basis of product type and application.
 
The global catheter market was valued at  around US $ 25,895.6Mn 2014 . The urinary catheter market accounted for 5.1% of global catheter market in 2014 and was  valued at US $ 1,326.0 million . Revenue contribution by urinary catheter market to the global catheter market is expected to  increase to US $ 1,755.0 by the end of 2021 expanding at a CAGR of 4.1% between 2015 and 2021 .
 

For Critical Insights On The Urinary Catheters Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/3268

 
The increasing prevalence of chronic diseases and growing ageing population are factors expected to positively affect the growth of the urinary catheter market across the globe.
 
By region, North America dominated the market with over 30% market share and is expected to remain dominant throughout the forecast period. The urinary catheter market in Asia and Latin America are expected to expand at a CAGRs of 4.7% and 4.6% respectively during the forecast period.
 

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/3268

Company Profile

  • Boston Scientific Corporation
  • Medtronic plc. 
  • Hollister Incorporate 
  • B. Braun Melsungen AG
  • Coloplast A/S
  • Becton, Dickinson and Company
  • Teleflex Incorporation
  • Cook Medical

 

]]>